China is Asia's key region of the future. The need for modernization is still as large as ever, and introduction of a market economy continues. There have also been noticeable improvements in conditions for foreign businesspeople such as more legal security (contract law), WTO membership, lower customs duties, privileges for foreign investors and step-by-step liberalization of trade. China welcomes you to the market of the future. And this market is growing rapidly.

China is undergoing enormous change. According to experts, double-digit growth rates are definitely expected in key market segments. As an exhibitor at analytica China 2008, the most important factor for you is that China is an import country. The domestic industry is interested in your products. And that will not change in the foreseeable future. That is what makes this enormous market so attractive and exciting, particularly for members of the chemical industry.

Now is the time to stake your claim.
Can a market have more charm?


Enormous growth potential
China is the leading importer of modern analysis instruments, diagnostics, reagents and laboratory equipment in Asia. Its most important suppliers include the United States, Japan and Germany. Analysis instruments have the best sales chances in the pharmaceuticals, petrochemical, environmental protection and research and development sectors (see diagram below).

"Environmental analysis" will experience a definite surge in demand, and environmental protection is one of the cornerstones of China's 10th five-year plan, which was just implemented.

Chemical industry

• China is already the third-largest producer of chemical products, after the USA and Japan.
• China will probably be number one in the world by the year 2015.

Pharmaceutical industry

• Annual growth on the pharma market is as high as 18%.
• China already leads the world in the sector for phytopharmaceutical products.
• Forecasts: By the year 2010, China will advance to fifth place worldwide (based on sales) and will be the largest sales market in the world by 2050.

Biotechnology

• China is the second-largest bioscience superpower in the Asian-Pacific region. Approximately 100 new companies are founded every year.
• China is an attractive research location: It costs some 6.5 million US dollars to develop medications until they can go to market in China, compared to some 800 million US dollars in western industrialized countries.